Carolina Reduzzi, Assistant Professor of Cancer Biology Research in Medicine and Director of Cristofanilli CTC Laboratory at Weill Cornell Medicine, posted on LinkedIn:
“The Liquid Biopsy Platform at Weill Cornell Medicine/EIPM is launching a new seminar series within the HemOnc Seminar Talk (HOST)!
HOSTing the Liquid Biopsy Series will build upon the establishment of the WCM EIPM Liquid Biopsy Platform, which was founded in 2024.
Each month it will explore the potential of various liquid biopsy technologies for cell-free DNA (cfDNA) and circulating tumor cell (CTC) analysis available at WCM.
The first seminar will be on April 11th at 12:30-1:30pm EST, with a talk by Hashem Alshurafa.
Here is the zoom link.
For more info, potential collaborations and to attend in person at WCM, send me a message!”
